Back to Nuveen Asset Management, LLC Nuveen Asset Management, LLC

ADMAADMA

Showing 2 of 23 quarters

Position history for Nuveen Asset Management, LLCNuveen Asset Management, LLC's holdings in ADMA Biologics Inc

As of its last 13F, for Q4 2024, Nuveen Asset Management held 4,552,317 shares of ADMA (ADMA Biologics), worth $78.1M. It reduced the position by 2,025,560 shares (-30.8%) from Q3 2024. Nuveen Asset Management held ADMA from Q2 2019 to Q4 2024, across 23 quarterly 13F filings.

Current Value

$78.1M

Current Shares

4.6M

Total Value Change

-$53.4M

Total Shares Change

-2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Decreased
4.6M
-30.8%
$78.1M0.0%$17.15
0
2024-Q3
Decreased
6.6M
-26.3%
$131.5M0.0%$19.99
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used